Related Experiment Videos
Febrile neutropenia
1Service de Médecine, Institut Jules Bordet, Brussels, Belgium.
Summary
Fever in cancer patients often signals infection, particularly in those with low white blood cell counts (granulocytopenia). Prompt diagnosis and treatment are crucial, even when the exact cause of fever remains unclear.
Area of Science:
- Oncology
- Infectious Diseases
- Hematology
Background:
- Fever is a frequent complication in cancer patients, often linked to malignancy.
- Infection is a primary cause of fever, especially in granulocytopenic patients.
- Fever can also arise from the malignancy itself (tumor necrosis, hemorrhage, pyrogens).
Purpose of the Study:
- To review the causes and management of fever in cancer patients.
- To highlight the challenges in diagnosing infections in immunocompromised individuals.
- To discuss the rationale behind empirical treatment strategies.
Main Methods:
- Review of existing literature on fever in cancer.
- Analysis of common pathogens and diagnostic difficulties.
- Discussion of therapeutic approaches, including empirical antifungal therapy.
Main Results:
- Infection is the most common cause of fever in cancer patients, particularly bacterial and fungal sepsis.
- Granulocytopenia significantly increases the risk and complexity of febrile episodes.
- Empirical amphotericin B is often administered to febrile granulocytopenic patients unresponsive to broad-spectrum antibiotics without documented bacteremia.
Conclusions:
- Fever in cancer patients requires prompt evaluation and management due to potential serious infections.
- Distinguishing between infection and malignancy-related fever is critical for appropriate treatment.
- Empirical antifungal therapy is a recognized strategy for persistent fever in neutropenic patients with suspected fungal infections.